November 19, 2025
1 min read

Biomanufacturer Antheia bolsters commercial drug ingredients prospects with TAPI alliance

Antheia is teaming up with TAPI—Teva’s active pharmaceutical ingredient and contract manufacturing business—in a bid to further commercialize its pipeline of biosynthetic drug ingredients and key start materials.

Leave a Reply

Your email address will not be published.

Previous Story

Novartis maps out plan for ‘flagship’ production hub in NC, eyes 700 hires

Next Story

Novo Nordisk Rolls Out Lower Prices for Ozempic and Wegovy

Previous Story

Novartis maps out plan for ‘flagship’ production hub in NC, eyes 700 hires

Next Story

Novo Nordisk Rolls Out Lower Prices for Ozempic and Wegovy

Latest from Blog

NEWS CENTER Maine

Through in-depth storytelling, through direct contact on digital on social platforms, through long-standing community service programs like Coats & Toys for Kids, Project Heat and Buddy to Buddy, NEWS CENTER Maine is
Go toTop